Novig is presently prohibited under Virginia law; the Commonwealth classifies it as a Schedule III controlled substance, making possession, distribution, or manufacture a criminal offense punishable by up to five years in prison and a $25,000 fine. However, a bipartisan bill scheduled for enactment on January 1 2026 will reclassify Novig to Schedule V, reducing penalties and introducing a regulated medical‑use framework. Until that date, individuals and businesses must treat Novig as illegal.
Current Legal Status of Novig in Virginia
Virginia Code § 18.2‑250 defines Novig as a prohibited drug. Courts have consistently upheld convictions for possession and sale, emphasizing the state’s zero‑tolerance stance. Law‑enforcement agencies routinely include Novig in drug‑seizure reports, and the Virginia Department of Health has warned that no legitimate medical application is recognized under current statutes.
Legislative Changes Effective 2026
The “Novig Regulation and Access Act” (HB 462) passed the General Assembly in March 2025 and was signed by the governor in June 2025. Key provisions include:
- Reclassification from Schedule III to Schedule V.
- Creation of a licensing system for physicians to prescribe Novig for chronic pain and certain neurological disorders.
- Establishment of a state‑run tracking database to monitor production and distribution.
- Reduction of criminal penalties for non‑violent possession to a misdemeanor with a maximum $5,000 fine.
Practical Implications for Residents and Businesses
Before 2026, any involvement with Novig carries felony risk. After reclassification, licensed practitioners may dispense Novig, but unlicensed possession will still be illegal. Businesses must obtain a Controlled Substances Registration certificate and implement inventory controls compliant with the new tracking system. Consumers should retain prescriptions and verify that dispensaries are state‑approved.
How to Remain Compliant
- Verify the licensing status of any provider or pharmacy before acquiring Novig.
- Keep copies of all prescriptions and receipts; the state may request documentation during audits.
- For employers, update workplace drug‑policy manuals to reflect the reduced penalties and new medical‑use exemptions.
- Attend continuing‑education seminars offered by the Virginia Board of Pharmacy to stay informed about reporting requirements.
- Consult a criminal‑defense attorney promptly if you are charged with a Novig‑related offense to explore potential diversion or mitigation options.
Frequently Asked Questions
What offenses can result from possessing Novig before 2026?
Possession is classified as a felony under § 18.2‑250, punishable by up to five years’ imprisonment and a $25,000 fine, regardless of quantity.
Can I obtain a medical prescription for Novig now?
No. The current statutes do not recognize any medical indication for Novig, and the Board of Medicine has not issued prescribing guidelines.
When does the new licensing system become operational?
The system will go live on February 1 2026, following a mandatory 30‑day registration window for eligible physicians and dispensaries.
Will prior convictions be expunged after reclassification?
The 2026 legislation includes a provision for retroactive relief, allowing eligible individuals to petition the circuit court for expungement of felony convictions related solely to Novig.
How will the tracking database affect privacy?
The database records only aggregate transaction data and is protected under Virginia’s data‑security statutes; personal health information remains confidential per HIPAA requirements.